# Atle Fund Management AB: Form 13F holdings

An institutional investment manager in STOCKHOLM. SEC CIK 1381843.

- Quarter ended: 2026-06-30
- Filed: 2026-07-24
- Reported value: $371.7m
- Positions: 39 (39 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1381843/000138184326000005/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ELI LILLY & CO (LLY)](/companies/lly.md) | COM | $35.8m | 9.6% | 29,821 |  | Reduced −9,901 |
| [MERCK & CO. INC (MRK)](/companies/mrk.md) | COM | $24.3m | 6.5% | 189,357 |  | Added +155,504 |
| [JOHNSON & JOHNSON (JNJ)](/companies/jnj.md) | COM | $21.7m | 5.8% | 85,425 |  | Reduced −6,952 |
| [ABBVIE INC (ABBV)](/companies/abbv.md) | COM | $16.2m | 4.4% | 64,325 |  | Reduced −43,856 |
| [CVS HEALTH CORP (CVS)](/companies/cvs.md) | COM | $15.1m | 4.1% | 146,102 |  | Added +122,329 |
| [THERMO FISHER SCIENTIFIC CORP (TMO)](/companies/tmo.md) | COM | $14.0m | 3.8% | 27,859 |  | Added +4,873 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $13.7m | 3.7% | 73,077 |  | Reduced −544,168 |
| [BIOGEN INC (BIIB)](/companies/biib.md) | COM | $13.6m | 3.6% | 62,781 |  | New +62,781 |
| [NEUROCRINE BIOSCIENCES INC (NBIX)](/companies/nbix.md) | COM | $12.3m | 3.3% | 72,898 |  | Reduced −16,787 |
| [MIRUM PHARMACEUTICALS INC (MIRM)](/companies/mirm.md) | COM | $11.8m | 3.2% | 100,807 |  | Reduced −94,961 |
| ALKERMES PLC | SHS | $11.2m | 3.0% | 213,329 |  | Reduced −29,144 |
| [IONIS PHARMACEUTICALS INC (IONS)](/companies/ions.md) | COM | $10.9m | 2.9% | 137,131 |  | Added +109,258 |
| [BEONE MEDICINES LTD-ADR (ONC)](/companies/onc.md) | SPONSORED ADS | $10.0m | 2.7% | 35,180 |  | Reduced −6,537 |
| [INTUITIVE SURGICAL INC (ISRG)](/companies/isrg.md) | COM NEW | $9.8m | 2.6% | 24,656 |  | Reduced −46,195 |
| [STRYKER CORPORATION (SYK)](/companies/syk.md) | COM | $9.5m | 2.6% | 30,283 |  | Added +3,448 |
| [VERTEX PHARMACEUTICALS INC (VRTX)](/companies/vrtx.md) | COM | $9.5m | 2.6% | 19,131 |  | Reduced −3,853 |
| [EDWARDS LIFESCIENCES CORP (EW)](/companies/ew.md) | COM | $9.3m | 2.5% | 103,230 |  | Reduced −3,288 |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $9.3m | 2.5% | 124,707 |  | Added +13,344 |
| [KRYSTAL BIOTECH, INC (KRYS)](/companies/krys.md) | COM | $8.9m | 2.4% | 24,019 |  | Reduced −13,560 |
| [CENCORA INC (COR)](/companies/cor.md) | COM | $8.8m | 2.4% | 31,126 |  | Added +7,656 |
| NEWAMSTERDAM PHARMA CO NV | ORDINARY SHARES | $8.4m | 2.3% | 248,848 |  | Added +154,052 |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $7.8m | 2.1% | 58,170 |  | Added +26,580 |
| [INCYTE CORP (INCY)](/companies/incy.md) | COM | $6.5m | 1.7% | 56,953 |  | Added +6,157 |
| [IRHYTHM TECHNOLOGIES INC (IRTC)](/companies/irtc.md) | COM | $6.4m | 1.7% | 54,102 |  | Added +31,780 |
| [BOSTON SCIENTIFC (BSX)](/companies/bsx.md) | COM | $6.2m | 1.7% | 146,381 |  | Added +105,949 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $6.2m | 1.7% | 58,378 |  | Reduced −39,060 |
| [TANGO THERAPEUTICS INC (TNGX)](/companies/tngx.md) | COM | $6.2m | 1.7% | 198,557 |  | Added +168,642 |
| [GILEAD SCIENCES INC (GILD)](/companies/gild.md) | COM | $5.8m | 1.6% | 46,142 |  | Reduced −1,825 |
| [CARDINAL HEALTH INC (CAH)](/companies/cah.md) | COM | $5.6m | 1.5% | 23,630 |  | Reduced −85,052 |
| [ORUKA THERAPEUTI (ORKA)](/companies/orka.md) | COM | $5.2m | 1.4% | 54,886 |  | New +54,886 |
| [SPYRE THERAPEUTICS INC (SYRE)](/companies/syre.md) | COM NEW | $5.1m | 1.4% | 57,030 |  | Reduced −5,705 |
| [DEXCOM INC (DXCM)](/companies/dxcm.md) | COM NEW | $4.8m | 1.3% | 71,846 |  | Reduced −512,486 |
| [BICARA THERAPEUTICS INC (BCAX)](/companies/bcax.md) | COM | $4.3m | 1.2% | 145,657 |  | Reduced −1,023,977 |
| [IDEAYA BIOSCIENCES INC (IDYA)](/companies/idya.md) | COM | $3.5m | 0.9% | 94,478 |  | Added +63,345 |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $3.5m | 0.9% | 33,313 |  | Reduced −107,983 |
| [DISC MEDICINE INC (IRON)](/companies/iron.md) | COM | $3.2m | 0.9% | 43,682 |  | Reduced −63,573 |
| [PYXIS ONCOLOGY INC (PYXS)](/companies/pyxs.md) | COMMON STOCK | $2.9m | 0.8% | 966,459 |  | Added +769,423 |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $2.3m | 0.6% | 1,048,593 |  | Added +1,006,762 |
| [JADE BIOSCIENCES (JBIO)](/companies/jbio.md) | COM NEW | $2.0m | 0.5% | 88,556 |  | New +88,556 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [AMGEN INC (AMGN)](/companies/amgn.md) | COM | $0 | 0.0% | 0 |  | Sold out −21,903 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −90,184 |
| [UNIVERSAL HEALTH SERVICES INC (UNH)](/companies/unh.md) | COM | $0 | 0.0% | 0 |  | Sold out −14,636 |

Source: SEC EDGAR, Form 13F-HR, accession 0001381843-26-000005. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.